Unique ID issued by UMIN | UMIN000027784 |
---|---|
Receipt number | R000031300 |
Scientific Title | A clinical study for the effects of a supplement containing black soybean coat extract on improving vascular endothelial function |
Date of disclosure of the study information | 2018/09/30 |
Last modified on | 2019/06/18 12:51:00 |
A clinical study for the effects of a supplement containing black soybean coat extract on improving vascular endothelial function
A clinical study for the effects of a supplement containing black soybean coat extract on improving vascular endothelial function
A clinical study for the effects of a supplement containing black soybean coat extract on improving vascular endothelial function
A clinical study for the effects of a supplement containing black soybean coat extract on improving vascular endothelial function
Japan |
None
Cardiology |
Others
NO
To evaluate the effects of intake of a supplement containing black soybean coat extract for 4 weeks on improving vascular endothelial function
Efficacy
Forearm blood flow determined by plethysmography
Deviation value of vascular aging, vascular age, Waveform index I, Waveform index II determined by accelerated plethysmography, systolic blood pressure, diastolic blood pressure and LDL cholesterol
Interventional
Cross-over
Randomized
Individual
Double blind -all involved are blinded
Placebo
2
Treatment
Food |
Intake of test food (4 weeks) -> Washout period (4 weeks) -> Intake of placebo (4 weeks)
Intake of placebo (4 weeks) -> Washout period (4 weeks) -> Intake of test food (4 weeks)
35 | years-old | <= |
65 | years-old | >= |
Male and Female
1) Healthy subjects aged from 35 to 65 years old
2) Subjects whose systolic blood pressure is 130 mmHg or more and less than 160 mmHg or diastolic blood pressure is 85 mmHg or more and less than 100 mmHg
3) Subjects whose serum LDL cholesterol is 120 mg/dL or more and less than 160 mg/dL
4) Subjects who have a briefing of the content of the present study, fully understanding and agreeing to its objective and being able to personally sign a written informed consent
1) Subjects who have severe liver, cardiovascular, respiratory, endocrine or metabolic diseases
2) Subjects who have the possibility of developing allergic symptoms by the test food
3) Subjects who are during pregnancy or lactation, and intend to be pregnant during the study period
4) Subjects having blood sample of 200 mL or more taken within 1 month, or 400 mL or more within 3 months (e.g. donated blood) prior to the start of the present study
5) Subjects who have a smoking habit
6) Subjects who took part in another clinical study within 3 months prior to the start of the present study or who is taking part in another clinical study
7) Subjects determined to be inappropriate by the investigator
20
1st name | |
Middle name | |
Last name | Masahiro Fukuda |
Fukuda Clinic
Director
Shin-Osaka Brick Building 2F, 1-6-1, Miyahara, Yodogawa-ku, Osaka, Osaka
06-6398-0203
fukuda@drmog.jp
1st name | |
Middle name | |
Last name | Tomohiro Sugino |
Soiken Inc.
Representative Director
Senri Life Science Center 13F, 1-4-2, Shinsenri-higashimachi, Toyonaka, Osaka
06-6871-8888
sugino@soiken.com
Soiken Inc.
Fujicco Co., Ltd.
Profit organization
NO
医療法人弘正会ふくだ内科クリニック(大阪府)
2018 | Year | 09 | Month | 30 | Day |
Unpublished
Completed
2017 | Year | 04 | Month | 15 | Day |
2017 | Year | 04 | Month | 15 | Day |
2017 | Year | 06 | Month | 17 | Day |
2017 | Year | 09 | Month | 23 | Day |
2017 | Year | 06 | Month | 16 | Day |
2019 | Year | 06 | Month | 18 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000031300